Latest Galien Foundation Stories

NEW YORK, Oct. 12, 2012 /PRNewswire/ -- The Galien Foundation Board announced today the final program for the 3(rd) Annual Galien Forum to be held in New York City at the Alexandria Center(TM) for Life Science on Tuesday, October 16 from 8AM to 4PM. (Logo: http://photos.prnewswire.com/prnh/20120416/NY87735LOGO) "Health decision executives from the world's leading regulatory bodies, biopharmaceutical and service companies will be on hand to discuss, debate and advance some of the...

NEW YORK, Aug. 9, 2012 /PRNewswire/ -- The Galien Foundation announced today that it has selected the NovoTTF(TM)-100A System as a finalist for the prestigious Prix Galien USA Award in Best Medical Technology. The Prix Galien Awards honor healthcare companies for outstanding efforts to improve the human condition through medical research and pharmacology. The winners are selected by a preeminent scientific committee that includes several Nobel Laureates. "The selection of the...

NEW YORK, July 9, 2012 /PRNewswire/ -- The Galien Foundation today announced the formal program of presenters and panels for its Third Galien Forum, scheduled for Tuesday, October 16, 2012 at the Alexandria Center for Life Science in New York City. The Galien Forum, conducted in conjunction with the prestigious Prix Galien Awards, features roundtable debates focusing on critical, global healthcare issues and challenges. This year's program includes a panel of CEO emeriti making...

NEW YORK, May 30, 2012 /PRNewswire/ -- The Galien Foundation announced today a new award category for the Prix Galien USA Awards, honoring innovation in biopharmaceuticals and medical technologies: "Best Medical Technology." The annual Prix Galien USA Awards recognizes outstanding achievement in improving the human condition through the development of innovative medical treatments and drug therapies. The 2012 awards ceremony will be held on October 16th in New York City at The...

The 'Prix Galien' Award - Biomedical industry's highest accolade for innovative research & development NEW YORK, Feb. 1, 2012 /PRNewswire-USNewswire/ -- The Galien Foundation announced today open enrollment for the annual Prix Galien USA Awards to recognize outstanding achievement in improving the human condition through the development of innovative medical treatments and drug therapies. The 2012 awards ceremony will be held on October 16th in New York City. Awards will be...

NEW YORK, July 14 /PRNewswire/ -- The Galien Foundation today announced the candidates for the 11th International Prix Galien, a global prize honoring extraordinary technical, scientific and clinical research accomplishments resulting in innovative medicines to advance the human condition: Humira® (adalimumab) from AbbottSoliris® (eculizumab) from AlexionNplate® (romiplostim) from AmgenXarelto® (rivaroxaban) from Bayer Schering PharmaOrencia® (abatacept) from Bristol-Myers...